皮肤至肿瘤距离预测T1a肾细胞癌经皮冷冻消融治疗失败
该回顾性多中心研究纳入2005至2015年间86例T1a肾细胞癌行经皮冷冻消融的患者,评估皮肤至肿瘤(STT)距离对治疗失败的影响。平均随访24个月,11例(12.8%)治疗失败;治疗失败组平均STT距离11.0 cm高于无失败组的8.4 cm(P=.002),STT距离为独立预测因子(OR 1.32,95%CI 1.04-1.69,P=.029),STT>10 cm者治疗失败风险增加约4倍(OR 4.43,95%CI 1.19-16.39,P=.018)。作者认为STT距离可能有助于评估治疗失败风险。
要点
- 治疗失败组平均STT距离11.0 cm,高于无失败组的8.4 cm(P=.002)。
- STT距离是治疗失败的独立预测因子(OR 1.32,95%CI 1.04-1.69)。
- STT距离>10 cm与治疗失败风险升高相关(OR 4.43,95%CI 1.19-16.39)。
核心结论
- STT距离是一种易于测量的术前变量,可能有助于评估T1a肾细胞癌经皮冷冻消融后治疗失败的风险。
研究设计与样本
- 回顾性多中心研究,纳入2005至2015年间2个学术中心接受经皮冷冻消融的86例T1a肾细胞癌患者。
主要发现
- 平均随访24个月(范围3-63个月)期间,11例(12.8%)发生治疗失败。
- 治疗失败组平均STT距离11.0 cm(范围6.3-20.1 cm),无失败组为8.4 cm(范围4.4-15.2 cm),差异有统计学意义(P=.002)。
- STT距离是治疗失败的独立预测因子(OR 1.32,95%CI 1.04-1.69,P=.029)。
- STT距离>10 cm与治疗失败风险升高相关(OR 4.43,95%CI 1.19-16.39,P=.018)。
- 肿瘤大小、R.E.N.A.L.肾肿瘤评分和冷冻探针数量与治疗失败无显著关联。
关键数值与推荐
- STT距离测量方法:术前CT图像上取0°、45°和90°三个方向皮肤至肿瘤中心距离的平均值。
- 治疗失败定义为文档记录的T1a肾细胞癌复发。
临床怎么用
- 作者认为,术前测量的STT距离可能有助于评估T1a肾细胞癌经皮冷冻消融治疗失败的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of skin-to-tumor (STT) distance on the risk for treatment failure following percutaneous cryoablation (PCA). METHODS: We retrospectively reviewed patients who underwent PCA with documented T1a recurrent renal cell carcinoma (RCC) at 2 academic centers between 2005 and 2015. Patient demographics, tumor characteristics, and perioperative and postoperative course variables were collected. Additionally, we measured the STT distance by averaging the distance from the skin to the center of the tumor at 0°, 45°, and 90° on preoperative computed tomography imaging. RESULTS: We identified 86 patients with documented T1a RCC. The mean age at the time of surgery was 69 years (range: 37-91 years), and the mean tumor size was 2.7 cm (range: 1.0-4.0 cm). With a mean follow-up of 24 months (range: 3-63 months), 11 (12.8%) treatment failures occurred. Patients with treatment failure had significantly higher mean STT distance than those without: 11.0 cm (range: 6.3-20.1 cm) compared to 8.4 cm (range: 4.4-15.2 cm), respectively (P = .002). STT distance was an independent predictor of treatment failure (odds ratio: 1.32, 95% confidence interval: 1.04-1.69, P = .029). STT distance greater than 10 cm had a fourfold increased risk of tumor treatment failure (odds ratio: 4.43, 95% confidence interval: 1.19-16.39, P = .018). Tumor size, R.E.N.A.L. Nephrometry score, and number of cryoprobes placed were not associated with treatment failure. CONCLUSION: STT, an easily measured preoperative variable, may inform the risk of RCC treatment failure following PCA.
引用
- Vernez SL, Okhunov Z, Kaler K, et al. Skin-to-tumor Distance Predicts Treatment Failure of T1A Renal Cell Carcinoma Following Percutaneous Cryoablation. Urology. 2017. PMID: 28652159. doi:10.1016/j.urology.2017.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。